在结肠直肠癌中准HIF-2α揭示了胆固醇生物合成依赖的ferroptotic脆弱性
bioRxiv : the preprint server for biology
|February 12, 2026
概括
结合低氧诱导因子2α (HIF-2α) 抑制与胆固醇生物合成阻断剂,如他类药物,有效抑制结肠直肠癌 (CRC) 的生长,并通过诱导铁亡促进细胞死亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢途径 代谢途径
背景情况:
- 大肠直肠癌 (CRC) 是癌症死亡的主要原因,在年轻人中发病率越来越高.
- 缺氧诱导因子2α (HIF-2α) 是结直肠瘤发生的验证驱动因素.
- HIF-2α抑制剂已被批准用于其他癌症,但尚未在CRC中探索.
研究的目的:
- 为了研究药理 HIF-2α 抑制在结肠直肠癌中的疗效.
- 在CRC中识别与HIF-2α阻断相关的治疗漏洞.
- 探索用于增强CRC治疗的组合策略.
主要方法:
- 在体外和体外结直肠癌模型.
- 通过CRISPR代谢查来识别药物依赖.
- 药理上抑制HIF-2α和胆固醇生物合成 (他类药物).
- 机理学研究,包括铁灭试验和遗传敲击.
主要成果:
- 仅仅抑制HIF-2α并没有抑制CRC的生长.
- 克里斯普尔查显示胆固醇生物合成是关键的依赖.
- 与HIF-2α抑制剂 (PT2385) 和他类药物的联合治疗协同减少了CRC细胞生长和诱导细胞死亡.
- 联合抑制促进了铁亡,其特点是脂质过氧化和减少抗氧化剂.
- 抑制铁亡可以逆转抗瘤效应.
结论:
- HIF-2α阻塞揭示了CRC胆固醇生物合成中的代谢漏洞.
- 对HIF-2α和胆固醇生物合成的双重向协同抑制了CRC的生长.
- 这种结合策略,利用FDA批准的他类药物,提供了一种临床可行的方法,以加强对结直肠癌的HIF-2α向治疗.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cholesterol: Significance and Regulation
1.5K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.5K
Biosynthesis in Bacteria
760
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
760
Biosynthesis of Polysaccharides
722
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
722
Biosynthesis of Lipids
677
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
677
Biosynthesis of Nucleic Acids
1.2K
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.2K


